Last $6.05 USD
Change Today +0.415 / 7.36%
Volume 403.6K
SNMX On Other Exchanges
Symbol
Exchange
SNMX is not on other exchanges.
As of 5:20 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

senomyx inc (SNMX) Snapshot

Open
$5.77
Previous Close
$5.64
Day High
$6.15
Day Low
$5.68
52 Week High
03/11/14 - $12.74
52 Week Low
12/18/13 - $4.23
Market Cap
262.3M
Average Volume 10 Days
329.4K
EPS TTM
$-0.29
Shares Outstanding
43.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SENOMYX INC (SNMX)

senomyx inc (SNMX) Related Bloomberg News

View More Bloomberg News

senomyx inc (SNMX) Related Businessweek News

View More BusinessWeek News

senomyx inc (SNMX) Details

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients for the packaged food, beverage, and ingredient supply industries using proprietary taste receptor-based assays and screening technologies. The company’s programs focus on the development and commercialization of sweet, savory, and salt flavor ingredients; bitter blockers; and cooling agents. It licenses flavor ingredients to its collaborators on an exclusive or co-exclusive basis. The company has product discovery and development collaborations with Ajinomoto Co., Inc., Firmenich SA, Nestlé SA, and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

113 Employees
Last Reported Date: 03/13/14
Founded in 1998

senomyx inc (SNMX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $402.2K
Executive Chairman
Total Annual Compensation: $551.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $336.7K
Chief Scientific Officer and Senior Vice Pres...
Total Annual Compensation: $372.6K
Chief Commercial Development Officer and Seni...
Total Annual Compensation: $349.7K
Compensation as of Fiscal Year 2013.

senomyx inc (SNMX) Key Developments

Senomyx Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for Full Year of 2014 and 2015

Senomyx Inc. announced unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported total revenues of $5,858,000 against $6,729,000 a year ago. Loss from operations was $4,417,000 against $3,483,000 a year ago. Net loss was $4,406,000 against $3,475,000 a year ago. Basic and diluted net loss per share was $0.10 against $0.09 a year ago. Development revenues were $4.5 million for the third quarter of 2014 and $5.9 million for the third quarter of 2013. The decreases were primarily attributable to an extension of the service period over which the $30 million upfront license fee related to the PepsiCo Sweet Taste Program collaboration is being recognized in accordance with PepsiCo's election in May 2014 to extend the service period of the collaboration an additional two years to August 2016. For the six months, the company reported total revenues of $21,405,000 against $21,878,000 a year ago, as an increase in commercial Revenue was offset by a reduction in development revenue. Loss from operations was $9,082,000 against $8,840,000 a year ago. Net loss was $9,055,000 against $8,812,000 a year ago. Basic and diluted net loss per share was $0.21 against $0.22 a year ago. The company recognized $2.2 million more revenue in the nine months ended September 30, 2013 compared to the same period in 2014, as a result of PepsiCo’s election in May of this year to extend the service period of the collaboration an additional 2 years to August, 2016. The company now expect commercial revenues to be approximately $6 million in 2014 with gross margins in a range between 85% and 90%. Accordingly, the company is revising the company's overall 2014 revenue guidance to be approximately $28 million. The company expects net loss of $13 million to $14 million resulting in a basic diluted net loss of $0.31 to $0.33 per share. The company also re-evaluating 2015 financial guidance based on the updated S617 commercialization timeline. The company currently believes it is unlikely that it will achieve the previously expected commercial revenue, or full year profitability guidance provided for 2015.

Senomyx Inc. to Report Q3, 2014 Results on Nov 06, 2014

Senomyx Inc. announced that they will report Q3, 2014 results at 11:00 AM, US Eastern Standard Time on Nov 06, 2014

Senomyx Inc., Q3 2014 Earnings Call, Nov 06, 2014

Senomyx Inc., Q3 2014 Earnings Call, Nov 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNMX:US $6.05 USD +0.415

SNMX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GLG Life Tech Corp C$0.43 CAD +0.005
PureCircle Ltd 552.50 GBp -1.00
Symrise AG €49.43 EUR +0.26
Takasago International Corp ¥516.00 JPY 0.00
Tate & Lyle PLC 590.50 GBp +8.50
View Industry Companies
 

Industry Analysis

SNMX

Industry Average

Valuation SNMX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.4x
Price/Book 9.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SENOMYX INC, please visit www.senomyx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.